보툴리눔톡신(보톡스) 시장 규모, 점유율, 동향 분석 보고서 : 제품별, 용도별, 최종 용도별, 지역별, 부문별 예측(2026-2033년)

Botulinum Toxin Market Summary

The global botulinum toxin market size was estimated at USD 13.2 billion in 2025 and is projected to reach USD 27.9 billion by 2033, growing at a CAGR of 9.9% from 2026 to 2033. Botulinum toxin is a protein and neurotoxin produced by the bacterium clostridium botulinum.

The toxin is a selective blocker of acetylcholine released from nerves, which blocks neural transmission from the nerves when injected into muscle. Botulinum toxin is one of the most exceptional substances encountered in medicine and science. The adoption of botulinum toxin in cosmetology has grown rapidly over the past decade, and at present it is one of the most common and widely performed aesthetic procedures in the world. The growing concern for aesthetic features in both developed and developing regions has led to a rise in the number of cosmetic procedures.

The availability of a variety of botulinum toxin products, such as botox, xeomin, dysport, and others, will accelerate the market growth. The increasing usage of botulinum toxin injection in several aesthetic procedures, including the treatment of glabellar lines, chemical browlift, forehead lines, and others, is expected to boost the botulinum toxin industry growth over the coming years. Presently, a few products of botulinum toxin - Type-A and only one product of Type-B (Myobloc) are commercially available in the market.

However, rising investment in R&D programs by major manufacturers to explore the therapeutic use of botulinum toxin is building opportunities for the expansion of its therapeutic application area soon. A shift from invasive to minimally invasive procedures is expected to fuel the market growth over the forecast period. Many people are opting for permanent procedures, such as fillers, fat grafting, and lip advancement.

Minimally invasive procedures offer advantages such as smaller incisions, shorter hospital stays, quick outpatient services, rapid wound healing, less pain, and a lower risk of complications than invasive surgeries. Thus, the demand for botulinum toxin is expected to increase over the forecast period.

Global Botulinum Toxin Market Report Segmentation

This report forecasts revenue growth at global, regional, and country levels and provides an analysis of latest industry trends in each of the sub-segments from 2021 to 2033. For the purpose of this study, Grand View Research has segmented the global botulinum toxin market report on the basis of product, application, end use, and region:

• Product Outlook (Revenue, USD Billion, 2021 - 2033)
• Type A
  • Botox
  • Dysport
  • Xeomin
  • Others
• Type B
• Application Outlook (Revenue, USD Billion, 2021 - 2033)
• Therapeutic
  • Chronic Migraine
  • Overactive Bladder
  • Cervical Dystonia
  • Spasticity
  • Others
  • Aesthetic
• Glabellar Lines
  • Crow's Feet
  • Forehead Lines
  • Others
• End Use Outlook (Revenue, USD Billion, 2021 - 2033)
• Hospitals
• Dermatology Clinics
• MedSpas and Cosmetic Centers
• Regional Outlook (Revenue, USD Billion, 2021 - 2033)
• North America
  • U.S.
  • Canada
  • Mexico
• Europe
  • UK
  • Germany
  • France
  • Italy
  • Spain
  • Sweden
  • Denmark
  • Norway
• Asia Pacific
  • India
  • Japan
  • China
  • South Korea
  • Australia
  • Thailand
• Latin America
  • Brazil
  • Argentina
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE
  • Kuwait

Table of Contents

Chapter 1. Methodology and Scope

• 1.1. Market Segmentation and Scope
• 1.2. Segment Definitions
  • 1.2.1. Product Type
  • 1.2.2. Application
  • 1.2.3. End Use
  • 1.2.4. Regional scope
  • 1.2.5. Estimates and forecasts timeline
• 1.3. Research Methodology
• 1.4. Information Procurement
  • 1.4.1. Purchased database
  • 1.4.2. GVR's internal database
  • 1.4.3. Secondary sources
  • 1.4.4. Primary research
  • 1.4.5. Details of primary research
    • 1.4.5.1. Data for primary interviews in North America
    • 1.4.5.2. Data for primary interviews in Europe
    • 1.4.5.3. Data for primary interviews in Asia Pacific
    • 1.4.5.4. Data for primary interviews in Latin America
    • 1.4.5.5. Data for Primary interviews in MEA
• 1.5. Information or Data Analysis
  • 1.5.1. Data analysis models
• 1.6. Market Formulation & Validation
• 1.7. Model Details
  • 1.7.1. Commodity flow analysis (Model 1)
  • 1.7.2. Approach 1: Commodity flow approach
  • 1.7.3. Volume price analysis (Model 2)
  • 1.7.4. Approach 2: Volume price analysis
• 1.8. List of Secondary Sources
• 1.9. List of Primary Sources
• 1.10. Objectives

Chapter 2. Executive Summary

• 2.1. Market Outlook
• 2.2. Segment Outlook
  • 2.2.1. Product Type outlook
  • 2.2.2. Application outlook
  • 2.2.3. End Use outlook
  • 2.2.4. Regional outlook
• 2.3. Competitive Insights

Chapter 3. Botulinum Toxin Market Variables, Trends & Scope

• 3.1. Market Lineage Outlook
  • 3.1.1. Parent Market Outlook
  • 3.1.2. Related/ancillary market outlook
• 3.2. Market Dynamics
  • 3.2.1. Market Driver Analysis
    • 3.2.1.1. Increasing number of patients having neurological disorders
    • 3.2.1.2. Rising preference for non-invasive or minimally invasive procedures
    • 3.2.1.3. Increasing concern regarding aesthetic appearance in 40-54 age group has increased the adoption rate
  • 3.2.2. Market Restraint Analysis
    • 3.2.2.1. High cost of cosmetic procedure
• 3.3. Botulinum Toxin Market Analysis Tools
  • 3.3.1. Industry Analysis - Porter's
    • 3.3.1.1. Bargaining power of suppliers
    • 3.3.1.2. Bargaining power of buyers
    • 3.3.1.3. Threat of substitutes
    • 3.3.1.4. Threat of new entrants
    • 3.3.1.5. Competitive rivalry
  • 3.3.2. PESTEL Analysis
    • 3.3.2.1. Political landscape
    • 3.3.2.2. Economic landscape
    • 3.3.2.3. Social landscape
    • 3.3.2.4. Technological landscape
    • 3.3.2.5. Environmental landscape
    • 3.3.2.6. Legal landscape

Chapter 4. Botulinum Toxin Market: Product Type Estimates & Trend Analysis

• 4.1. Segment Dashboard
• 4.2. Botulinum Toxin Market: Product Type Movement Analysis
• 4.3. Botulinum Toxin Market by Product Type Outlook (USD Million)
• 4.4. Market Size & Forecasts and Trend Analyses, 2021 to 2033 for the following
• 4.5. Type A
  • 4.5.1. Type A Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 4.5.2. Botox
    • 4.5.2.1. Botox Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 4.5.3. Dysport
    • 4.5.3.1. Dysport Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 4.5.4. Xeomin
    • 4.5.4.1. Xeomin Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 4.5.5. Others
    • 4.5.5.1. Others Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
• 4.6. Type B
  • 4.6.1. Type B Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 5. Botulinum Toxin Market: Applicatio Estimates & Trend Analysis

• 5.1. Segment Dashboard
• 5.2. Botulinum Toxin Market: Application Movement Analysis
• 5.3. Botulinum Toxin Market by Application Outlook (USD Million)
• 5.4. Market Size & Forecasts and Trend Analyses, 2021 to 2033 for the following
• 5.5. Therapeutic
  • 5.5.1. Therapeutic Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 5.5.2. Chronic Migraine
    • 5.5.2.1. Chronic Migraine Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 5.5.3. Overactive Bladder
    • 5.5.3.1. Overactive Bladder Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 5.5.4. Cervical Dystonia
    • 5.5.4.1. Cervical Dystonia Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 5.5.5. Spasticity
    • 5.5.5.1. Spasticity Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 5.5.6. Others
    • 5.5.6.1. Others Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
• 5.6. Aesthetic
  • 5.6.1. Aesthetic Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 5.6.2. Glabellar Lines
    • 5.6.2.1. Glabellar Lines Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 5.6.3. Crow's Feet
    • 5.6.3.1. Crow's Feet Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 5.6.4. Forehead Lines
    • 5.6.4.1. Forehead Lines Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 5.6.5. Others
    • 5.6.5.1. Others Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 6. Botulinum Toxin Market: End Use Estimates & Trend Analysis

• 6.1. Segment Dashboard
• 6.2. Botulinum Toxin Market: End Use Movement Analysis
• 6.3. Botulinum Toxin Market by End Use Outlook (USD Million)
• 6.4. Market Size & Forecasts and Trend Analyses, 2021 to 2033 for the following
• 6.5. Hospitals
  • 6.5.1. Hospitals Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
• 6.6. Dermatology Clinics
  • 6.6.1. Dermatology Clinics Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
• 6.7. MedSpas and Cosmetic Centers
  • 6.7.1. MedSpas and Cosmetic Centers Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 7. Botulinum Toxin Market: Regional Estimates & Trend Analysis

• 7.1. Regional Dashboard
• 7.2. Regional Botulinum Toxin Market Movement Analysis
• 7.3. Botulinum Toxin Market: Regional Estimates & Trend Analysis by Product Type & End Use
• 7.4. Market Size & Forecasts and Trend Analyses, 2021 to 2033 for the following
• 7.5. North America
  • 7.5.1. North America Botulinum Toxin Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 7.5.2. U.S.
    • 7.5.2.1. U.S. Botulinum Toxin Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 7.5.3. Canada
    • 7.5.3.1. Canada Botulinum Toxin Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 7.5.4. Mexico
    • 7.5.4.1. Mexico Botulinum Toxin Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 7.5.5. Europe
  • 7.5.6. Europe Botulinum Toxin Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 7.5.7. UK
    • 7.5.7.1. UK Botulinum Toxin Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 7.5.8. Germany
    • 7.5.8.1. Germany Botulinum Toxin Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 7.5.9. France
    • 7.5.9.1. France Botulinum Toxin Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 7.5.10. Italy
    • 7.5.10.1. Italy Botulinum Toxin Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 7.5.11. Spain
    • 7.5.11.1. Spain Botulinum Toxin Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 7.5.12. Sweden
    • 7.5.12.1. Sweden Botulinum Toxin Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 7.5.13. Denmark
    • 7.5.13.1. Denmark Botulinum Toxin Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 7.5.14. Norway
    • 7.5.14.1. Norway Botulinum Toxin Market Estimates and Forecasts, 2021 - 2033 (USD Million)
• 7.6. Asia Pacific
  • 7.6.1. Asia Pacific Botulinum Toxin Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 7.6.2. Japan
    • 7.6.2.1. Japan Botulinum Toxin Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 7.6.3. China
    • 7.6.3.1. China Botulinum Toxin Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 7.6.4. India
    • 7.6.4.1. Key Country Dynamics
    • 7.6.4.2. India Botulinum Toxin Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 7.6.5. South Korea
    • 7.6.5.1. South Korea Botulinum Toxin Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 7.6.6. Australia
    • 7.6.6.1. Australia Botulinum Toxin Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 7.6.7. Thailand
    • 7.6.7.1. Thailand Botulinum Toxin Market Estimates and Forecasts, 2021 - 2033 (USD Million)
• 7.7. Latin America
  • 7.7.1. Latin America Botulinum Toxin Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 7.7.2. Brazil
    • 7.7.2.1. Brazil Botulinum Toxin Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 7.7.3. Argentina
    • 7.7.3.1. Argentina Botulinum Toxin Market Estimates and Forecasts, 2021 - 2033 (USD Million)
• 7.8. Middle East & Africa
  • 7.8.1. Middle East & Africa Botulinum Toxin Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 7.8.2. South Africa
    • 7.8.2.1. South Africa Botulinum Toxin Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 7.8.3. Saudi Arabia
    • 7.8.3.1. Saudi Arabia Botulinum Toxin Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 7.8.4. UAE
    • 7.8.4.1. UAE Botulinum Toxin Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 7.8.5. Kuwait
    • 7.8.5.1. Kuwait Botulinum Toxin Market Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 8. Competitive Landscape

• 8.1. Market Participant Categorization
• 8.2. Key Company Profiles
  • 8.2.1. Ipsen Group
    • 8.2.1.1. Company Overview
    • 8.2.1.2. Financial Performance
    • 8.2.1.3. Product Benchmarking
    • 8.2.1.4. Strategic Initiatives
  • 8.2.2. Allergan, Inc.
    • 8.2.2.1. Company Overview
    • 8.2.2.2. Financial Performance
    • 8.2.2.3. Product Benchmarking
    • 8.2.2.4. Strategic Initiatives
  • 8.2.3. Metabiologics
    • 8.2.3.1. Company Overview
    • 8.2.3.2. Financial Performance
    • 8.2.3.3. Product Benchmarking
    • 8.2.3.4. Strategic Initiatives
  • 8.2.4. Merz Pharma
    • 8.2.4.1. Company Overview
    • 8.2.4.2. Financial Performance
    • 8.2.4.3. Product Benchmarking
    • 8.2.4.4. Strategic Initiatives
  • 8.2.5. US Worldmeds
    • 8.2.5.1. Company Overview
    • 8.2.5.2. Financial Performance
    • 8.2.5.3. Product Benchmarking
    • 8.2.5.4. Strategic Initiatives
  • 8.2.6. Evolus
    • 8.2.6.1. Company Overview
    • 8.2.6.2. Financial Performance
    • 8.2.6.3. Product Benchmarking
    • 8.2.6.4. Strategic Initiatives
  • 8.2.7. Galderma
    • 8.2.7.1. Company Overview
    • 8.2.7.2. Financial Performance
    • 8.2.7.3. Product Benchmarking
    • 8.2.7.4. Strategic Initiatives
  • 8.2.8. Medy-Tox, Inc.
    • 8.2.8.1. Company Overview
    • 8.2.8.2. Financial Performance
    • 8.2.8.3. Product Benchmarking
    • 8.2.8.4. Strategic Initiatives
  • 8.2.9. Lanzhou Institute of Biological Products
    • 8.2.9.1. Company Overview
    • 8.2.9.2. Financial Performance
    • 8.2.9.3. Product Benchmarking
    • 8.2.9.4. Strategic Initiatives